The oncogenic role of FBXO22 was shown in colorectal, liver, lung and breast cancers [20–23], while the suppressive role of cancer metastasis was also been proposed in lung cancer and breast cancer [23, 24]. This evidence concerns the gene FBXO22 and breast carcinoma.